C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/5377 (2006.01) A61P 7/02 (2006.01)
Patent
CA 2727378
The present invention relates to a new co-crystal compound of 5-chloro-N- ({(5S)-2-oxo-3-[4-(3-oxo-4-morpholi- nyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid, to processes for preparing it, to medicinal products comprising it, and to the use thereof in fighting diseases.
La présente invention concerne un nouveau composé de 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phényl]-1,3-oxazolidin-5-yl}-méthyl)-2-thiophènecarboxamide (rivaroxaban) et d'acide malonique contenant des co-cristaux, son procédé de préparation, les médicaments contenant ce nouveau composé ainsi que leur utilisation pour lutter contre des maladies.
Faehnrich Karsten
Grunenberg Alfons
Gushurst Karen Sue
Keil Birgit
Queckenberg Olaf
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
New co-crystal compound of rivaroxaban and malonic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New co-crystal compound of rivaroxaban and malonic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New co-crystal compound of rivaroxaban and malonic acid will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1692634